141 related articles for article (PubMed ID: 38373870)
21. Perioperative chemotherapy for resectable colorectal liver metastases: where now?
Jones RP; Malik HZ; Fenwick SW; Poston GJ
Eur J Surg Oncol; 2013 Aug; 39(8):807-11. PubMed ID: 23726258
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
[TBL] [Abstract][Full Text] [Related]
23. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
[TBL] [Abstract][Full Text] [Related]
24. Predictive Factors for the Survival Outcomes of Preoperative Chemotherapy in Patients with Resectable and Borderline Resectable Colorectal Cancer with Liver Metastasis.
Inworn N; Senavat P; Aleenajitpong N; Chingchaimaneesri M; Siripoon T; Srirattanapong S; Suragul W; Ngamphaiboon N
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3037-3047. PubMed ID: 37774055
[TBL] [Abstract][Full Text] [Related]
25. Topics related to neoadjuvant chemotherapy for resectable liver metastases from colorectal cancer.
Ke S; Zhan S; Zhu H; Yan D
J BUON; 2018; 23(2):296-301. PubMed ID: 29745068
[TBL] [Abstract][Full Text] [Related]
26. Impact of baseline gadoxetic acid-enhanced liver magnetic resonance and diffusion-weighted imaging in resectable colorectal liver metastases: A prospective, monocentric study.
Moretto R; Borelli B; Boraschi P; Roffi N; Donati F; Antoniotti C; Della Pina C; Colombatto P; Balestri R; Signori S; Gigoni R; Guidoccio F; Volterrani D; Masi G; Cremolini C; Urbani L
Surg Oncol; 2022 Sep; 44():101836. PubMed ID: 35998501
[TBL] [Abstract][Full Text] [Related]
27. A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.
Wong R; Cunningham D; Barbachano Y; Saffery C; Valle J; Hickish T; Mudan S; Brown G; Khan A; Wotherspoon A; Strimpakos AS; Thomas J; Compton S; Chua YJ; Chau I
Ann Oncol; 2011 Sep; 22(9):2042-2048. PubMed ID: 21285134
[TBL] [Abstract][Full Text] [Related]
28. The many faces of ALPPS: surgical indications and techniques among surgeons collaborating in the international registry.
Buac S; Schadde E; Schnitzbauer AA; Vogt K; Hernandez-Alejandro R
HPB (Oxford); 2016 May; 18(5):442-8. PubMed ID: 27154808
[TBL] [Abstract][Full Text] [Related]
29. Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group.
Nieuwenhuizen S; Puijk RS; van den Bemd B; Aldrighetti L; Arntz M; van den Boezem PB; Bruynzeel AME; Burgmans MC; de Cobelli F; Coolsen MME; Dejong CHC; Derks S; Diederik A; van Duijvendijk P; Eker HH; Engelsman AF; Erdmann JI; Fütterer JJ; Geboers B; Groot G; Haasbeek CJA; Janssen JJ; de Jong KP; Kater GM; Kazemier G; Kruimer JWH; Leclercq WKG; van der Leij C; Manusama ER; Meier MAJ; van der Meijs BB; Melenhorst MCAM; Nielsen K; Nijkamp MW; Potters FH; Prevoo W; Rietema FJ; Ruarus AH; Ruiter SJS; Schouten EAC; Serafino GP; Sietses C; Swijnenburg RJ; Timmer FEF; Versteeg KS; Vink T; de Vries JJJ; de Wilt JHW; Zonderhuis BM; Scheffer HJ; van den Tol PMP; Meijerink MR
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635230
[TBL] [Abstract][Full Text] [Related]
30. Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.
Zhong W; Xu B; Lu Y; Chang J; Xu L; Zhao H; Che X
J Gastroenterol Hepatol; 2024 May; 39(5):908-919. PubMed ID: 38323685
[TBL] [Abstract][Full Text] [Related]
31. A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases.
Chun YJ; Kim SG; Lee KW; Cho SH; Kim TW; Baek JY; Park YS; Hong S; Chu CW; Beom SH; Jung M; Shin SJ; Ahn JB
Clin Colorectal Cancer; 2020 Sep; 19(3):e140-e150. PubMed ID: 32402681
[TBL] [Abstract][Full Text] [Related]
32. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
33. Limitations in resectability of colorectal liver metastases 2020 - A systematic approach for clinicians and patients.
Schadde E; Grunhagen DJ; Verhoef C; Krzywon L; Metrakos P
Semin Cancer Biol; 2021 Jun; 71():10-20. PubMed ID: 32980499
[TBL] [Abstract][Full Text] [Related]
34. PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
Jones RP; Malik HZ; Fenwick SW; Terlizzo M; O'Grady E; Stremitzer S; Gruenberger T; Rees M; Plant G; Figueras J; Albiol M; Adam R; Awad S; Poston GJ
Eur J Surg Oncol; 2016 Dec; 42(12):1866-1872. PubMed ID: 27561844
[TBL] [Abstract][Full Text] [Related]
35. Multicentre study of perioperative
Allard MA; Nishioka Y; Beghdadi N; Imai K; Gelli M; Yamashita S; Kitano Y; Kokudo T; Yamashita YI; Sa Cunha A; Vibert E; Elias D; Cherqui D; Goere D; Adam R; Baba H; Hasegawa K
BJS Open; 2019 Oct; 3(5):678-686. PubMed ID: 31592094
[TBL] [Abstract][Full Text] [Related]
36. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines.
Bonney GK; Chew CA; Lodge P; Hubbard J; Halazun KJ; Trunecka P; Muiesan P; Mirza DF; Isaac J; Laing RW; Iyer SG; Chee CE; Yong WP; Muthiah MD; Panaro F; Sanabria J; Grothey A; Moodley K; Chau I; Chan ACY; Wang CC; Menon K; Sapisochin G; Hagness M; Dueland S; Line PD; Adam R
Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):933-946. PubMed ID: 34506756
[TBL] [Abstract][Full Text] [Related]
37. [Oncosurgical strategies for metastatic liver cancer].
Adam R; Hoti E; Bredt LC
Cir Esp; 2011 Jan; 89(1):10-9. PubMed ID: 21176894
[TBL] [Abstract][Full Text] [Related]
38. Outcomes Following Different Thermal Ablation Strategies in Patients with Unresectable Colorectal Liver Metastases.
Li J; Liu G; Xie X; Zhang D; Zheng R; Yang H; Zhong H; Dai G; Yu J; Liang P
Radiology; 2023 Aug; 308(2):e223135. PubMed ID: 37581502
[TBL] [Abstract][Full Text] [Related]
39. [Preoperative chemotherapy in the surgical treatment of colorectal liver metastases].
Dede K; Láng I; Pörneczi B; Mester G; Fekete A; Kőszegi G; Mersich T; Besznyák I; Bursics A
Magy Seb; 2013 Dec; 66(6):325-30. PubMed ID: 24333977
[TBL] [Abstract][Full Text] [Related]
40. Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection.
Mattar RE; Al-Alem F; Simoneau E; Hassanain M
World J Gastroenterol; 2016 Jan; 22(2):567-81. PubMed ID: 26811608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
